Cyclic Boronates Inhibit All Classes of β-Lactamase.

β-Lactamase-mediated resistance is a growing threat to the continued use of β-lactam antibiotics. The use of the β-lactam-based serine-β-lactamase (SBL) inhibitors clavulanic acid, sulbactam, tazobactam, and, more recently, the non-β-lactam inhibitor avibactam has extended the utility of β-lactams a...

詳細記述

書誌詳細
主要な著者: Cahill, S, Cain, R, Wang, D, Lohans, C, Wareham, D, Oswin, H, Mohammed, J, Spencer, J, Fishwick, C, McDonough, M, Schofield, C, Brem, J
フォーマット: Journal article
言語:English
出版事項: American Society for Microbiology 2017

類似資料